Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Frizzled-2: A potential novel target for molecular pancreatic cancer therapy.

Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.

Oncol Lett. 2014 Jan;7(1):74-78. Epub 2013 Nov 12.

2.

Gastric cancer cell proliferation is suppressed by frizzled-2 short hairpin RNA.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Int J Oncol. 2015 Mar;46(3):1018-24. doi: 10.3892/ijo.2015.2830. Epub 2015 Jan 9.

PMID:
25586465
3.

Short hairpin RNA of frizzled-2 suppresses the proliferation of hepatocellular carcinoma cells.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M.

Oncol Lett. 2014 Oct;8(4):1519-1522. Epub 2014 Aug 4.

4.

SU11274 suppresses proliferation and motility of pancreatic cancer cells.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Oncol Lett. 2015 Sep;10(3):1468-1472. Epub 2015 Jul 2.

5.

Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.

Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.

World J Gastroenterol. 2010 Apr 21;16(15):1854-8.

6.

Suppression of hepatocellular carcinoma cell proliferation by short hairpin RNA of frizzled 2 with Sonazoid-enhanced irradiation.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.

Int J Oncol. 2016 Jan;48(1):123-9. doi: 10.3892/ijo.2015.3259. Epub 2015 Nov 20.

PMID:
26648389
7.

Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.

Wang XP, Yazawa K, Yang J, Kohn D, Fisher WE, Brunicardi FC.

J Gastrointest Surg. 2004 Jan;8(1):98-108; discussion 106-8.

PMID:
14746841
8.

SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells.

Fujimoto T, Tomizawa M, Yokosuka O.

Int J Oncol. 2009 Oct;35(4):861-6.

PMID:
19724923
9.

A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.

Zhao X, Li DC, Zhao H, Li Z, Wang JX, Zhu DM, Zhou J, Cen JN.

Oncol Rep. 2012 Mar;27(3):628-36. doi: 10.3892/or.2011.1602. Epub 2011 Dec 21.

PMID:
22200682
10.

Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells.

Yang S, Lee KT, Lee JY, Lee JK, Lee KH, Rhee JC.

Tumour Biol. 2013 Oct;34(5):2731-9. doi: 10.1007/s13277-013-0825-9. Epub 2013 May 8.

PMID:
23653380
11.

Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.

He SB, Yuan Y, Wang L, Yu MJ, Zhu YB, Zhu XG.

J Exp Clin Cancer Res. 2011 Nov 22;30:109. doi: 10.1186/1756-9966-30-109.

12.

Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-alpha.

Suzuki T, Sato F, Kondo J, Liu Y, Kusumi T, Fujimoto K, Kato Y, Sato T, Kijima H.

Biomed Res. 2008 Apr;29(2):99-103.

13.

Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.

Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q.

Mol Cancer. 2011 Aug 31;10:106. doi: 10.1186/1476-4598-10-106.

14.

Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.

Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J, Büchler MW.

Clin Cancer Res. 2001 Jan;7(1):105-12.

15.

SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin.

Cho IR, Koh SS, Malilas W, Srisuttee R, Moon J, Choi YW, Horio Y, Oh S, Chung YH.

Biochem Biophys Res Commun. 2012 Jun 29;423(2):270-5. doi: 10.1016/j.bbrc.2012.05.107. Epub 2012 May 26.

PMID:
22640743
16.

Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.

Shen YM, Yang XC, Song ML, Qin CH, Yang C, Sun YH.

Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):69-77.

17.

Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.

Inami K, Kajino K, Abe M, Hagiwara Y, Maeda M, Suyama M, Watanabe S, Hino O.

Oncol Rep. 2008 Dec;20(6):1375-80.

PMID:
19020717
18.

Insulin-like growth factor I receptor involvement in proliferation of NOR-P1 cells in serum-free media.

Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.

J Cell Biochem. 2012 Aug;113(8):2714-20. doi: 10.1002/jcb.24149.

PMID:
22441995
19.

Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.

Zheng C, Jia W, Tang Y, Zhao H, Jiang Y, Sun S.

J Exp Clin Cancer Res. 2012 Oct 3;31:84. doi: 10.1186/1756-9966-31-84.

20.

Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.

Biliran H Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD.

Clin Cancer Res. 2005 Aug 15;11(16):6075-86.

Items per page

Supplemental Content

Write to the Help Desk